Bausch Health Companies Bond Debt To Equity

071734AC1   64.00  23.48  26.84%   
Bausch Health Companies fundamentals help investors to digest information that contributes to Bausch's financial success or failures. It also enables traders to predict the movement of Bausch Bond. The fundamental analysis module provides a way to measure Bausch's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bausch bond.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Bausch Health Companies Corporate Bond Debt To Equity Analysis

Bausch's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

D/E

 = 

Total Debt

Total Equity

More About Debt To Equity | All Equity Analysis
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Competition

According to the company disclosure, Bausch Health Companies has a Debt To Equity of 0.0%. This indicator is about the same for the Manufacturing average (which is currently at 0.0) sector and about the same as Industrial (which currently averages 0.0) industry. This indicator is about the same for all United States bonds average (which is currently at 0.0).

Bausch Debt To Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bausch's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the bonds which would be a good addition to a portfolio. Peer analysis of Bausch could also be used in its relative valuation, which is a method of valuing Bausch by comparing valuation metrics of similar companies.
Bausch Health cannot be rated in Debt To Equity category at this point.

About Bausch Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bausch Health Companies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bausch using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bausch Health Companies based on its fundamental data. In general, a quantitative approach, as applied to this corporate bond, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Bausch Bond

Bausch financial ratios help investors to determine whether Bausch Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bausch with respect to the benefits of owning Bausch security.